Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001237334-25-000003

Director sold 3,000 shares at an average $423.21 ($1,269,630)

  • Director acquired 3,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

CAUSEY CHRISTOPHER · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-02 Exercise or conversion : show line 1 in the form 10b5-1 +3,000 $132.30 $396,900 7,865 D
2025-09-02 Sale : show line 2 in the form 10b5-1 −1,000 $419.63 $419,630 6,865 D
2025-09-02 Sale : show line 3 in the form 10b5-1 −1,000 $430.00 $430,000 5,865 D
2025-09-02 Sale : show line 4 in the form 10b5-1 −1,000 $420.00 $420,000 4,865 D
Open-market sales · 3,000 sh · avg $423.21 · $1,269,630

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-09-02 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option −3,000 $132.30 2027-06-28 3,000 0 D
Loading xslF345X05/primarydocument.xml…